Intervention Review

You have free access to this content

Interventions for treating scabies

  1. Mark Strong1,*,
  2. Paul Johnstone2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 10 AUG 2010

DOI: 10.1002/14651858.CD000320.pub2

Database Title

Additional Information

How to Cite

Strong M, Johnstone P. Interventions for treating scabies. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD000320. DOI: 10.1002/14651858.CD000320.pub2.

Author Information

  1. 1

    University of Sheffield, School of Health and Related Research, Sheffield, UK

  2. 2

    Blenheim House, NHS Yorkshire and the Humber, Leeds, UK

*Mark Strong, School of Health and Related Research, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK. m.strong@sheffield.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (739K)Full (917K)
[Figure 1]
Figure 1. Forest plot of comparison: 1 Ivermectin versus placebo, outcome: 1.1 Treatment failure in clinically diagnosed cases.
[Figure 2]
Figure 2. Forest plot of comparison: 2 Ivermectin versus permethrin, outcome: 2.1 Treatment failure in clinically diagnosed cases.
[Figure 3]
Figure 3. Forest plot of comparison: 3 Ivermectin versus lindane, outcome: 3.1 Treatment failure in clinically diagnosed cases.
[Figure 4]
Figure 4. Forest plot of comparison: 4 Ivermectin versus benzyl benzoate, outcome: 4.1 Treatment failure in clinically diagnosed cases.
[Figure 5]
Figure 5. Forest plot of comparison: 4 Ivermectin versus benzyl benzoate, outcome: 4.2 Itch persistence.
[Figure 6]
Figure 6. Forest plot of comparison: 5 Permethrin versus crotamiton, outcome: 5.1 Treatment failure in clinically diagnosed cases.
[Figure 7]
Figure 7. Forest plot of comparison: 5 Permethrin versus crotamiton, outcome: 5.2 Treatment failure in microscopically diagnosed cases.
[Figure 8]
Figure 8. Forest plot of comparison: 5 Permethrin versus crotamiton, outcome: 5.3 Itch persistence.
[Figure 9]
Figure 9. Forest plot of comparison: 6 Permethrin versus lindane, outcome: 6.1 Treatment failure in clinically diagnosed cases.
[Figure 10]
Figure 10. Forest plot of comparison: 6 Permethrin versus lindane, outcome: 6.2 Treatment failure in microscopically diagnosed cases.
[Figure 11]
Figure 11. Forest plot of comparison: 6 Permethrin versus lindane, outcome: 6.3 Itch persistence.
[Figure 12]
Figure 12. Forest plot of comparison: 7 Permethrin versus benzyl benzoate, outcome: 7.1 Treatment failure in clinically diagnosed cases.
[Figure 13]
Figure 13. Forest plot of comparison: 8 Permethrin versus natural synergized pyrethrins, outcome: 8.1 Itch persistence.
[Figure 14]
Figure 14. Forest plot of comparison: 9 Crotamiton versus lindane, outcome: 9.1 Treatment failure in clinically diagnosed cases.
[Figure 15]
Figure 15. Forest plot of comparison: 9 Crotamiton versus lindane, outcome: 9.2 Treatment failure in microscopically diagnosed cases.
[Figure 16]
Figure 16. Forest plot of comparison: 10 Lindane versus sulfur, outcome: 10.1 Treatment failure in clinically diagnosed cases.
[Figure 17]
Figure 17. Forest plot of comparison: 10 Lindane versus sulfur, outcome: 10.2 Itch persistence.
[Figure 18]
Figure 18. Forest plot of comparison: 11 Benzyl benzoate versus sulfur, outcome: 11.1 Treatment failure in clinically diagnosed cases.
[Figure 19]
Figure 19. Forest plot of comparison: 12 Benzyl benzoate versus natural synergized pyrethrins, outcome: 12.1 Treatment failure in clinically diagnosed cases.
[Figure 20]
Figure 20. Forest plot of comparison: 12 Benzyl benzoate versus natural synergized pyrethrins, outcome: 12.2 Treatment failure in microscopically diagnosed cases.
[Figure 21]
Figure 21. Forest plot of comparison: 12 Benzyl benzoate versus natural synergized pyrethrins, outcome: 12.3 Itch persistence.
[Figure 22]
Figure 22. Forest plot of comparison: 13 Benzyl benzoate: one application versus two applications, outcome: 13.1 Treatment failure in clinically diagnosed cases.
[Figure 23]
Figure 23. Forest plot of comparison: 14 Lindane: short application versus long application, outcome: 14.1 Itch persistence.
[Figure 24]
Figure 24. Forest plot of comparison: 15 Sulfur: pork fat vehicle versus cold cream vehicle, outcome: 15.1 Treatment failure in clinically diagnosed cases.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Ivermectin versus placebo, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Ivermectin versus permethrin, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Ivermectin versus lindane, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 4.1]
Analysis 4.1. Comparison 4 Ivermectin versus benzyl benzoate, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 4.2]
Analysis 4.2. Comparison 4 Ivermectin versus benzyl benzoate, Outcome 2 Itch persistence.
[Analysis 5.1]
Analysis 5.1. Comparison 5 Permethrin versus crotamiton, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 5.2]
Analysis 5.2. Comparison 5 Permethrin versus crotamiton, Outcome 2 Treatment failure in microscopically diagnosed cases.
[Analysis 5.3]
Analysis 5.3. Comparison 5 Permethrin versus crotamiton, Outcome 3 Itch persistence.
[Analysis 6.1]
Analysis 6.1. Comparison 6 Permethrin versus lindane, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 6.2]
Analysis 6.2. Comparison 6 Permethrin versus lindane, Outcome 2 Treatment failure in microscopically diagnosed cases.
[Analysis 6.3]
Analysis 6.3. Comparison 6 Permethrin versus lindane, Outcome 3 Itch persistence.
[Analysis 7.1]
Analysis 7.1. Comparison 7 Permethrin versus benzyl benzoate, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 8.1]
Analysis 8.1. Comparison 8 Permethrin versus natural synergized pyrethrins, Outcome 1 Itch persistence.
[Analysis 9.1]
Analysis 9.1. Comparison 9 Crotamiton versus lindane, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 9.2]
Analysis 9.2. Comparison 9 Crotamiton versus lindane, Outcome 2 Treatment failure in microscopically diagnosed cases.
[Analysis 10.1]
Analysis 10.1. Comparison 10 Lindane versus sulfur, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 10.2]
Analysis 10.2. Comparison 10 Lindane versus sulfur, Outcome 2 Itch persistence.
[Analysis 11.1]
Analysis 11.1. Comparison 11 Benzyl benzoate versus sulfur, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 12.1]
Analysis 12.1. Comparison 12 Benzyl benzoate versus natural synergized pyrethrins, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 12.2]
Analysis 12.2. Comparison 12 Benzyl benzoate versus natural synergized pyrethrins, Outcome 2 Treatment failure in microscopically diagnosed cases.
[Analysis 12.3]
Analysis 12.3. Comparison 12 Benzyl benzoate versus natural synergized pyrethrins, Outcome 3 Itch persistence.
[Analysis 13.1]
Analysis 13.1. Comparison 13 Benzyl benzoate: one application versus two applications, Outcome 1 Treatment failure in clinically diagnosed cases.
[Analysis 14.1]
Analysis 14.1. Comparison 14 Lindane: short application versus long application, Outcome 1 Itch persistence.
[Analysis 15.1]
Analysis 15.1. Comparison 15 Sulfur: pork fat vehicle versus cold cream vehicle, Outcome 1 Treatment failure in clinically diagnosed cases.
View Full Article (HTML) Summary (57K)Standard (739K)Full (917K)